Deep Medicine Acquisition Corp. (DMAQU): Price and Financial Metrics


Deep Medicine Acquisition Corp. (DMAQU): $10.11

0.03 (+0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DMAQU Stock Price Chart Interactive Chart >

Price chart for DMAQU

DMAQU Price/Volume Stats

Current price $10.11 52-week high $10.15
Prev. close $10.08 52-week low $10.03
Day low $10.09 Volume 102,100
Day high $10.15 Avg. volume 80,789
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap N/A

Deep Medicine Acquisition Corp. (DMAQU) Company Bio


Deep Medicine Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.


DMAQU Latest News Stream


Event/Time News Detail
Loading, please wait...

DMAQU Latest Social Stream


Loading social stream, please wait...

View Full DMAQU Social Stream

Latest DMAQU News From Around the Web

Below are the latest news stories about Deep Medicine Acquisition Corp that investors may wish to consider to help them evaluate DMAQU as an investment opportunity.

Deep Medicine Acquisition Corp. Completes Upsized $126,500,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option

New York, NY, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQU) (the “Company”) today announced the closing of its upsized initial public offering of 12,650,000 units at a price to the public of $10.00 per unit, which includes 1,650,000 units issued pursuant to the underwriters’ exercise of over-allotment option in full, with the offering raising gross proceeds of $126,500,000. The units commenced trading on Wednesday, October 27, 2021, on The Nasdaq Global Market

Yahoo | October 29, 2021

Deep Medicine Acquisition Corp. Announces Pricing of Upsized $110 Million Initial Public Offering

New York, NY, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (the “Company”) announced today that it priced its upsized initial public offering of 11,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “DMAQU” beginning October 27, 2021. Each unit consists of one share of Class A common stock and one right to receive one-tenth of one share of Class A common stock upon the consummation of

Yahoo | October 27, 2021

Read More 'DMAQU' Stories Here

DMAQU Price Returns

1-mo N/A
3-mo N/A
6-mo 0.00%
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 3.3517 seconds.